Global Acinetobacter Infections Treatment Supply, Demand and Key Producers, 2026-2032
The global Acinetobacter Infections Treatment market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032).
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
This report studies the global Acinetobacter Infections Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Acinetobacter Infections Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Acinetobacter Infections Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Acinetobacter Infections Treatment total market, 2021-2032, (USD Million)
Global Acinetobacter Infections Treatment total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Acinetobacter Infections Treatment total market, key domestic companies, and share, (USD Million)
Global Acinetobacter Infections Treatment revenue by player, revenue and market share 2021-2026, (USD Million)
Global Acinetobacter Infections Treatment total market by Type, CAGR, 2021-2032, (USD Million)
Global Acinetobacter Infections Treatment total market by Pipeline, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Acinetobacter Infections Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Acinetobacter Infections Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Pipeline. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Acinetobacter Infections Treatment Market, By Region:
1. How big is the global Acinetobacter Infections Treatment market?
2. What is the demand of the global Acinetobacter Infections Treatment market?
3. What is the year over year growth of the global Acinetobacter Infections Treatment market?
4. What is the total value of the global Acinetobacter Infections Treatment market?
5. Who are the Major Players in the global Acinetobacter Infections Treatment market?
6. What are the growth factors driving the market demand?
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
This report studies the global Acinetobacter Infections Treatment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Acinetobacter Infections Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Acinetobacter Infections Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Acinetobacter Infections Treatment total market, 2021-2032, (USD Million)
Global Acinetobacter Infections Treatment total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Acinetobacter Infections Treatment total market, key domestic companies, and share, (USD Million)
Global Acinetobacter Infections Treatment revenue by player, revenue and market share 2021-2026, (USD Million)
Global Acinetobacter Infections Treatment total market by Type, CAGR, 2021-2032, (USD Million)
Global Acinetobacter Infections Treatment total market by Pipeline, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Acinetobacter Infections Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Acinetobacter Infections Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Pipeline. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Acinetobacter Infections Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sulbactam
- Carbapenems
- Aminoglycosides
- Polymyxins
- Tetracyclines
- Others
- ETX2514
- Nacubactam RG6080
- Arenicin
- VXD-001
- Small Molecule Antibiotic
- AR-401 mAB
- LCB01-0371 (PO)
- GN-4474
- Antibacterial Antibody
- Others
- Entasis Therapeutics
- Roche
- Adenium Biotech
- Vaxdyn
- Hsiri Therapeutics
- Aridis Pharmaceuticals
- LegoChem Biosciences
- Atterx Biotherapeutics
- Achaogen
- Peptilogics
- Sealife PHARMA
- Shionogi
- Techulon
- Tetraphase Pharmaceuticals
1. How big is the global Acinetobacter Infections Treatment market?
2. What is the demand of the global Acinetobacter Infections Treatment market?
3. What is the year over year growth of the global Acinetobacter Infections Treatment market?
4. What is the total value of the global Acinetobacter Infections Treatment market?
5. Who are the Major Players in the global Acinetobacter Infections Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Acinetobacter Infections Treatment Introduction
1.2 World Acinetobacter Infections Treatment Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Acinetobacter Infections Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Acinetobacter Infections Treatment Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.3 China Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.4 Europe Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.5 Japan Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.6 South Korea Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.7 ASEAN Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.8 India Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Acinetobacter Infections Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.2 World Acinetobacter Infections Treatment Consumption Value by Region
2.2.1 World Acinetobacter Infections Treatment Consumption Value by Region (2021-2026)
2.2.2 World Acinetobacter Infections Treatment Consumption Value Forecast by Region (2027-2032)
2.3 United States Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.4 China Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.5 Europe Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.6 Japan Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.7 South Korea Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.8 ASEAN Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.9 India Acinetobacter Infections Treatment Consumption Value (2021-2032)
3 WORLD ACINETOBACTER INFECTIONS TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Acinetobacter Infections Treatment Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Acinetobacter Infections Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Acinetobacter Infections Treatment in 2025
3.2.3 Global Concentration Ratios (CR8) for Acinetobacter Infections Treatment in 2025
3.3 Acinetobacter Infections Treatment Company Evaluation Quadrant
3.4 Acinetobacter Infections Treatment Market: Overall Company Footprint Analysis
3.4.1 Acinetobacter Infections Treatment Market: Region Footprint
3.4.2 Acinetobacter Infections Treatment Market: Company Product Type Footprint
3.4.3 Acinetobacter Infections Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Acinetobacter Infections Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Acinetobacter Infections Treatment Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Acinetobacter Infections Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Acinetobacter Infections Treatment Consumption Value Comparison
4.2.1 United States VS China: Acinetobacter Infections Treatment Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Acinetobacter Infections Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Acinetobacter Infections Treatment Companies and Market Share, 2021-2026
4.3.1 United States Based Acinetobacter Infections Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026)
4.4 China Based Companies Acinetobacter Infections Treatment Revenue and Market Share, 2021-2026
4.4.1 China Based Acinetobacter Infections Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026)
4.5 Rest of World Based Acinetobacter Infections Treatment Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Acinetobacter Infections Treatment Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Acinetobacter Infections Treatment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Sulbactam
5.2.2 Carbapenems
5.2.3 Aminoglycosides
5.2.4 Polymyxins
5.2.5 Tetracyclines
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Acinetobacter Infections Treatment Market Size by Type (2021-2026)
5.3.2 World Acinetobacter Infections Treatment Market Size by Type (2027-2032)
5.3.3 World Acinetobacter Infections Treatment Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PIPELINE
6.1 World Acinetobacter Infections Treatment Market Size Overview by Pipeline: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pipeline
6.2.1 ETX2514
6.2.2 Nacubactam RG6080
6.2.3 Arenicin
6.2.4 VXD-001
6.2.5 Small Molecule Antibiotic
6.2.6 AR-401 mAB
6.2.7 LCB01-0371 (PO)
6.2.8 GN-4474
6.2.9 Antibacterial Antibody
6.3 Market Segment by Pipeline
6.3.1 World Acinetobacter Infections Treatment Market Size by Pipeline (2021-2026)
6.3.2 World Acinetobacter Infections Treatment Market Size by Pipeline (2027-2032)
6.3.3 World Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2021-2032)
7 COMPANY PROFILES
7.1 Entasis Therapeutics
7.1.1 Entasis Therapeutics Details
7.1.2 Entasis Therapeutics Major Business
7.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Product and Services
7.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Entasis Therapeutics Recent Developments/Updates
7.1.6 Entasis Therapeutics Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche Acinetobacter Infections Treatment Product and Services
7.2.4 Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Adenium Biotech
7.3.1 Adenium Biotech Details
7.3.2 Adenium Biotech Major Business
7.3.3 Adenium Biotech Acinetobacter Infections Treatment Product and Services
7.3.4 Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Adenium Biotech Recent Developments/Updates
7.3.6 Adenium Biotech Competitive Strengths & Weaknesses
7.4 Vaxdyn
7.4.1 Vaxdyn Details
7.4.2 Vaxdyn Major Business
7.4.3 Vaxdyn Acinetobacter Infections Treatment Product and Services
7.4.4 Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Vaxdyn Recent Developments/Updates
7.4.6 Vaxdyn Competitive Strengths & Weaknesses
7.5 Hsiri Therapeutics
7.5.1 Hsiri Therapeutics Details
7.5.2 Hsiri Therapeutics Major Business
7.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Product and Services
7.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Hsiri Therapeutics Recent Developments/Updates
7.5.6 Hsiri Therapeutics Competitive Strengths & Weaknesses
7.6 Aridis Pharmaceuticals
7.6.1 Aridis Pharmaceuticals Details
7.6.2 Aridis Pharmaceuticals Major Business
7.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product and Services
7.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Aridis Pharmaceuticals Recent Developments/Updates
7.6.6 Aridis Pharmaceuticals Competitive Strengths & Weaknesses
7.7 LegoChem Biosciences
7.7.1 LegoChem Biosciences Details
7.7.2 LegoChem Biosciences Major Business
7.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Product and Services
7.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 LegoChem Biosciences Recent Developments/Updates
7.7.6 LegoChem Biosciences Competitive Strengths & Weaknesses
7.8 Atterx Biotherapeutics
7.8.1 Atterx Biotherapeutics Details
7.8.2 Atterx Biotherapeutics Major Business
7.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Product and Services
7.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Atterx Biotherapeutics Recent Developments/Updates
7.8.6 Atterx Biotherapeutics Competitive Strengths & Weaknesses
7.9 Achaogen
7.9.1 Achaogen Details
7.9.2 Achaogen Major Business
7.9.3 Achaogen Acinetobacter Infections Treatment Product and Services
7.9.4 Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Achaogen Recent Developments/Updates
7.9.6 Achaogen Competitive Strengths & Weaknesses
7.10 Peptilogics
7.10.1 Peptilogics Details
7.10.2 Peptilogics Major Business
7.10.3 Peptilogics Acinetobacter Infections Treatment Product and Services
7.10.4 Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Peptilogics Recent Developments/Updates
7.10.6 Peptilogics Competitive Strengths & Weaknesses
7.11 Sealife PHARMA
7.11.1 Sealife PHARMA Details
7.11.2 Sealife PHARMA Major Business
7.11.3 Sealife PHARMA Acinetobacter Infections Treatment Product and Services
7.11.4 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Sealife PHARMA Recent Developments/Updates
7.11.6 Sealife PHARMA Competitive Strengths & Weaknesses
7.12 Shionogi
7.12.1 Shionogi Details
7.12.2 Shionogi Major Business
7.12.3 Shionogi Acinetobacter Infections Treatment Product and Services
7.12.4 Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Shionogi Recent Developments/Updates
7.12.6 Shionogi Competitive Strengths & Weaknesses
7.13 Techulon
7.13.1 Techulon Details
7.13.2 Techulon Major Business
7.13.3 Techulon Acinetobacter Infections Treatment Product and Services
7.13.4 Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Techulon Recent Developments/Updates
7.13.6 Techulon Competitive Strengths & Weaknesses
7.14 Tetraphase Pharmaceuticals
7.14.1 Tetraphase Pharmaceuticals Details
7.14.2 Tetraphase Pharmaceuticals Major Business
7.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product and Services
7.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Tetraphase Pharmaceuticals Recent Developments/Updates
7.14.6 Tetraphase Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Acinetobacter Infections Treatment Industry Chain
8.2 Acinetobacter Infections Treatment Upstream Analysis
8.3 Acinetobacter Infections Treatment Midstream Analysis
8.4 Acinetobacter Infections Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Acinetobacter Infections Treatment Introduction
1.2 World Acinetobacter Infections Treatment Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Acinetobacter Infections Treatment Total Market by Region (by Headquarter Location)
1.3.1 World Acinetobacter Infections Treatment Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.3 China Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.4 Europe Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.5 Japan Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.6 South Korea Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.7 ASEAN Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.3.8 India Based Company Acinetobacter Infections Treatment Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Acinetobacter Infections Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.2 World Acinetobacter Infections Treatment Consumption Value by Region
2.2.1 World Acinetobacter Infections Treatment Consumption Value by Region (2021-2026)
2.2.2 World Acinetobacter Infections Treatment Consumption Value Forecast by Region (2027-2032)
2.3 United States Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.4 China Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.5 Europe Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.6 Japan Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.7 South Korea Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.8 ASEAN Acinetobacter Infections Treatment Consumption Value (2021-2032)
2.9 India Acinetobacter Infections Treatment Consumption Value (2021-2032)
3 WORLD ACINETOBACTER INFECTIONS TREATMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Acinetobacter Infections Treatment Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Acinetobacter Infections Treatment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Acinetobacter Infections Treatment in 2025
3.2.3 Global Concentration Ratios (CR8) for Acinetobacter Infections Treatment in 2025
3.3 Acinetobacter Infections Treatment Company Evaluation Quadrant
3.4 Acinetobacter Infections Treatment Market: Overall Company Footprint Analysis
3.4.1 Acinetobacter Infections Treatment Market: Region Footprint
3.4.2 Acinetobacter Infections Treatment Market: Company Product Type Footprint
3.4.3 Acinetobacter Infections Treatment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Acinetobacter Infections Treatment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Acinetobacter Infections Treatment Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Acinetobacter Infections Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Acinetobacter Infections Treatment Consumption Value Comparison
4.2.1 United States VS China: Acinetobacter Infections Treatment Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Acinetobacter Infections Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Acinetobacter Infections Treatment Companies and Market Share, 2021-2026
4.3.1 United States Based Acinetobacter Infections Treatment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026)
4.4 China Based Companies Acinetobacter Infections Treatment Revenue and Market Share, 2021-2026
4.4.1 China Based Acinetobacter Infections Treatment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026)
4.5 Rest of World Based Acinetobacter Infections Treatment Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Acinetobacter Infections Treatment Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Acinetobacter Infections Treatment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Sulbactam
5.2.2 Carbapenems
5.2.3 Aminoglycosides
5.2.4 Polymyxins
5.2.5 Tetracyclines
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Acinetobacter Infections Treatment Market Size by Type (2021-2026)
5.3.2 World Acinetobacter Infections Treatment Market Size by Type (2027-2032)
5.3.3 World Acinetobacter Infections Treatment Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PIPELINE
6.1 World Acinetobacter Infections Treatment Market Size Overview by Pipeline: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pipeline
6.2.1 ETX2514
6.2.2 Nacubactam RG6080
6.2.3 Arenicin
6.2.4 VXD-001
6.2.5 Small Molecule Antibiotic
6.2.6 AR-401 mAB
6.2.7 LCB01-0371 (PO)
6.2.8 GN-4474
6.2.9 Antibacterial Antibody
6.3 Market Segment by Pipeline
6.3.1 World Acinetobacter Infections Treatment Market Size by Pipeline (2021-2026)
6.3.2 World Acinetobacter Infections Treatment Market Size by Pipeline (2027-2032)
6.3.3 World Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2021-2032)
7 COMPANY PROFILES
7.1 Entasis Therapeutics
7.1.1 Entasis Therapeutics Details
7.1.2 Entasis Therapeutics Major Business
7.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Product and Services
7.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Entasis Therapeutics Recent Developments/Updates
7.1.6 Entasis Therapeutics Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche Acinetobacter Infections Treatment Product and Services
7.2.4 Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Adenium Biotech
7.3.1 Adenium Biotech Details
7.3.2 Adenium Biotech Major Business
7.3.3 Adenium Biotech Acinetobacter Infections Treatment Product and Services
7.3.4 Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Adenium Biotech Recent Developments/Updates
7.3.6 Adenium Biotech Competitive Strengths & Weaknesses
7.4 Vaxdyn
7.4.1 Vaxdyn Details
7.4.2 Vaxdyn Major Business
7.4.3 Vaxdyn Acinetobacter Infections Treatment Product and Services
7.4.4 Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Vaxdyn Recent Developments/Updates
7.4.6 Vaxdyn Competitive Strengths & Weaknesses
7.5 Hsiri Therapeutics
7.5.1 Hsiri Therapeutics Details
7.5.2 Hsiri Therapeutics Major Business
7.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Product and Services
7.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Hsiri Therapeutics Recent Developments/Updates
7.5.6 Hsiri Therapeutics Competitive Strengths & Weaknesses
7.6 Aridis Pharmaceuticals
7.6.1 Aridis Pharmaceuticals Details
7.6.2 Aridis Pharmaceuticals Major Business
7.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product and Services
7.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Aridis Pharmaceuticals Recent Developments/Updates
7.6.6 Aridis Pharmaceuticals Competitive Strengths & Weaknesses
7.7 LegoChem Biosciences
7.7.1 LegoChem Biosciences Details
7.7.2 LegoChem Biosciences Major Business
7.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Product and Services
7.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 LegoChem Biosciences Recent Developments/Updates
7.7.6 LegoChem Biosciences Competitive Strengths & Weaknesses
7.8 Atterx Biotherapeutics
7.8.1 Atterx Biotherapeutics Details
7.8.2 Atterx Biotherapeutics Major Business
7.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Product and Services
7.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Atterx Biotherapeutics Recent Developments/Updates
7.8.6 Atterx Biotherapeutics Competitive Strengths & Weaknesses
7.9 Achaogen
7.9.1 Achaogen Details
7.9.2 Achaogen Major Business
7.9.3 Achaogen Acinetobacter Infections Treatment Product and Services
7.9.4 Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Achaogen Recent Developments/Updates
7.9.6 Achaogen Competitive Strengths & Weaknesses
7.10 Peptilogics
7.10.1 Peptilogics Details
7.10.2 Peptilogics Major Business
7.10.3 Peptilogics Acinetobacter Infections Treatment Product and Services
7.10.4 Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Peptilogics Recent Developments/Updates
7.10.6 Peptilogics Competitive Strengths & Weaknesses
7.11 Sealife PHARMA
7.11.1 Sealife PHARMA Details
7.11.2 Sealife PHARMA Major Business
7.11.3 Sealife PHARMA Acinetobacter Infections Treatment Product and Services
7.11.4 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Sealife PHARMA Recent Developments/Updates
7.11.6 Sealife PHARMA Competitive Strengths & Weaknesses
7.12 Shionogi
7.12.1 Shionogi Details
7.12.2 Shionogi Major Business
7.12.3 Shionogi Acinetobacter Infections Treatment Product and Services
7.12.4 Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Shionogi Recent Developments/Updates
7.12.6 Shionogi Competitive Strengths & Weaknesses
7.13 Techulon
7.13.1 Techulon Details
7.13.2 Techulon Major Business
7.13.3 Techulon Acinetobacter Infections Treatment Product and Services
7.13.4 Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Techulon Recent Developments/Updates
7.13.6 Techulon Competitive Strengths & Weaknesses
7.14 Tetraphase Pharmaceuticals
7.14.1 Tetraphase Pharmaceuticals Details
7.14.2 Tetraphase Pharmaceuticals Major Business
7.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product and Services
7.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Tetraphase Pharmaceuticals Recent Developments/Updates
7.14.6 Tetraphase Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Acinetobacter Infections Treatment Industry Chain
8.2 Acinetobacter Infections Treatment Upstream Analysis
8.3 Acinetobacter Infections Treatment Midstream Analysis
8.4 Acinetobacter Infections Treatment Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Acinetobacter Infections Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Acinetobacter Infections Treatment Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Acinetobacter Infections Treatment Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Acinetobacter Infections Treatment Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Acinetobacter Infections Treatment Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Acinetobacter Infections Treatment Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Acinetobacter Infections Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Acinetobacter Infections Treatment Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Acinetobacter Infections Treatment Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Acinetobacter Infections Treatment Players in 2025
Table 12. World Acinetobacter Infections Treatment Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Acinetobacter Infections Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Acinetobacter Infections Treatment Players
Table 15. Acinetobacter Infections Treatment Market: Company Product Type Footprint
Table 16. Acinetobacter Infections Treatment Market: Company Product Application Footprint
Table 17. Acinetobacter Infections Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Acinetobacter Infections Treatment Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Acinetobacter Infections Treatment Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Acinetobacter Infections Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 23. China Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 26. Rest of World Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Acinetobacter Infections Treatment Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 29. World Acinetobacter Infections Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Acinetobacter Infections Treatment Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (USD Million)
Table 32. World Acinetobacter Infections Treatment Market Size by Pipeline, (USD Million), 2021 & 2025 & 2032
Table 33. World Acinetobacter Infections Treatment Market Size by Pipeline (2021-2026) & (USD Million)
Table 34. World Acinetobacter Infections Treatment Market Size by Pipeline (2027-2032) & (USD Million)
Table 35. Entasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Entasis Therapeutics Major Business
Table 37. Entasis Therapeutics Acinetobacter Infections Treatment Product and Services
Table 38. Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Entasis Therapeutics Recent Developments/Updates
Table 40. Entasis Therapeutics Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Acinetobacter Infections Treatment Product and Services
Table 44. Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Adenium Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Adenium Biotech Major Business
Table 49. Adenium Biotech Acinetobacter Infections Treatment Product and Services
Table 50. Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Adenium Biotech Recent Developments/Updates
Table 52. Adenium Biotech Competitive Strengths & Weaknesses
Table 53. Vaxdyn Basic Information, Manufacturing Base and Competitors
Table 54. Vaxdyn Major Business
Table 55. Vaxdyn Acinetobacter Infections Treatment Product and Services
Table 56. Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Vaxdyn Recent Developments/Updates
Table 58. Vaxdyn Competitive Strengths & Weaknesses
Table 59. Hsiri Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. Hsiri Therapeutics Major Business
Table 61. Hsiri Therapeutics Acinetobacter Infections Treatment Product and Services
Table 62. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hsiri Therapeutics Recent Developments/Updates
Table 64. Hsiri Therapeutics Competitive Strengths & Weaknesses
Table 65. Aridis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Aridis Pharmaceuticals Major Business
Table 67. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 68. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Aridis Pharmaceuticals Recent Developments/Updates
Table 70. Aridis Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 72. LegoChem Biosciences Major Business
Table 73. LegoChem Biosciences Acinetobacter Infections Treatment Product and Services
Table 74. LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LegoChem Biosciences Recent Developments/Updates
Table 76. LegoChem Biosciences Competitive Strengths & Weaknesses
Table 77. Atterx Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Atterx Biotherapeutics Major Business
Table 79. Atterx Biotherapeutics Acinetobacter Infections Treatment Product and Services
Table 80. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Atterx Biotherapeutics Recent Developments/Updates
Table 82. Atterx Biotherapeutics Competitive Strengths & Weaknesses
Table 83. Achaogen Basic Information, Manufacturing Base and Competitors
Table 84. Achaogen Major Business
Table 85. Achaogen Acinetobacter Infections Treatment Product and Services
Table 86. Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Achaogen Recent Developments/Updates
Table 88. Achaogen Competitive Strengths & Weaknesses
Table 89. Peptilogics Basic Information, Manufacturing Base and Competitors
Table 90. Peptilogics Major Business
Table 91. Peptilogics Acinetobacter Infections Treatment Product and Services
Table 92. Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Peptilogics Recent Developments/Updates
Table 94. Peptilogics Competitive Strengths & Weaknesses
Table 95. Sealife PHARMA Basic Information, Manufacturing Base and Competitors
Table 96. Sealife PHARMA Major Business
Table 97. Sealife PHARMA Acinetobacter Infections Treatment Product and Services
Table 98. Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sealife PHARMA Recent Developments/Updates
Table 100. Sealife PHARMA Competitive Strengths & Weaknesses
Table 101. Shionogi Basic Information, Manufacturing Base and Competitors
Table 102. Shionogi Major Business
Table 103. Shionogi Acinetobacter Infections Treatment Product and Services
Table 104. Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shionogi Recent Developments/Updates
Table 106. Shionogi Competitive Strengths & Weaknesses
Table 107. Techulon Basic Information, Manufacturing Base and Competitors
Table 108. Techulon Major Business
Table 109. Techulon Acinetobacter Infections Treatment Product and Services
Table 110. Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Techulon Recent Developments/Updates
Table 112. Techulon Competitive Strengths & Weaknesses
Table 113. Tetraphase Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Tetraphase Pharmaceuticals Major Business
Table 115. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 116. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Tetraphase Pharmaceuticals Recent Developments/Updates
Table 118. Tetraphase Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Global Key Players of Acinetobacter Infections Treatment Upstream (Raw Materials)
Table 120. Global Acinetobacter Infections Treatment Typical Customers
Table 1. World Acinetobacter Infections Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Acinetobacter Infections Treatment Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Acinetobacter Infections Treatment Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Acinetobacter Infections Treatment Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Acinetobacter Infections Treatment Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Acinetobacter Infections Treatment Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Acinetobacter Infections Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Acinetobacter Infections Treatment Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Acinetobacter Infections Treatment Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Acinetobacter Infections Treatment Players in 2025
Table 12. World Acinetobacter Infections Treatment Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Acinetobacter Infections Treatment Company Evaluation Quadrant
Table 14. Head Office of Key Acinetobacter Infections Treatment Players
Table 15. Acinetobacter Infections Treatment Market: Company Product Type Footprint
Table 16. Acinetobacter Infections Treatment Market: Company Product Application Footprint
Table 17. Acinetobacter Infections Treatment Mergers & Acquisitions Activity
Table 18. United States VS China Acinetobacter Infections Treatment Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Acinetobacter Infections Treatment Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Acinetobacter Infections Treatment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 23. China Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Acinetobacter Infections Treatment Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 26. Rest of World Based Acinetobacter Infections Treatment Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Acinetobacter Infections Treatment Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Acinetobacter Infections Treatment Revenue Market Share (2021-2026)
Table 29. World Acinetobacter Infections Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Acinetobacter Infections Treatment Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (USD Million)
Table 32. World Acinetobacter Infections Treatment Market Size by Pipeline, (USD Million), 2021 & 2025 & 2032
Table 33. World Acinetobacter Infections Treatment Market Size by Pipeline (2021-2026) & (USD Million)
Table 34. World Acinetobacter Infections Treatment Market Size by Pipeline (2027-2032) & (USD Million)
Table 35. Entasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Entasis Therapeutics Major Business
Table 37. Entasis Therapeutics Acinetobacter Infections Treatment Product and Services
Table 38. Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Entasis Therapeutics Recent Developments/Updates
Table 40. Entasis Therapeutics Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Acinetobacter Infections Treatment Product and Services
Table 44. Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Adenium Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Adenium Biotech Major Business
Table 49. Adenium Biotech Acinetobacter Infections Treatment Product and Services
Table 50. Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Adenium Biotech Recent Developments/Updates
Table 52. Adenium Biotech Competitive Strengths & Weaknesses
Table 53. Vaxdyn Basic Information, Manufacturing Base and Competitors
Table 54. Vaxdyn Major Business
Table 55. Vaxdyn Acinetobacter Infections Treatment Product and Services
Table 56. Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Vaxdyn Recent Developments/Updates
Table 58. Vaxdyn Competitive Strengths & Weaknesses
Table 59. Hsiri Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. Hsiri Therapeutics Major Business
Table 61. Hsiri Therapeutics Acinetobacter Infections Treatment Product and Services
Table 62. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hsiri Therapeutics Recent Developments/Updates
Table 64. Hsiri Therapeutics Competitive Strengths & Weaknesses
Table 65. Aridis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Aridis Pharmaceuticals Major Business
Table 67. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 68. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Aridis Pharmaceuticals Recent Developments/Updates
Table 70. Aridis Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 72. LegoChem Biosciences Major Business
Table 73. LegoChem Biosciences Acinetobacter Infections Treatment Product and Services
Table 74. LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LegoChem Biosciences Recent Developments/Updates
Table 76. LegoChem Biosciences Competitive Strengths & Weaknesses
Table 77. Atterx Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Atterx Biotherapeutics Major Business
Table 79. Atterx Biotherapeutics Acinetobacter Infections Treatment Product and Services
Table 80. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Atterx Biotherapeutics Recent Developments/Updates
Table 82. Atterx Biotherapeutics Competitive Strengths & Weaknesses
Table 83. Achaogen Basic Information, Manufacturing Base and Competitors
Table 84. Achaogen Major Business
Table 85. Achaogen Acinetobacter Infections Treatment Product and Services
Table 86. Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Achaogen Recent Developments/Updates
Table 88. Achaogen Competitive Strengths & Weaknesses
Table 89. Peptilogics Basic Information, Manufacturing Base and Competitors
Table 90. Peptilogics Major Business
Table 91. Peptilogics Acinetobacter Infections Treatment Product and Services
Table 92. Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Peptilogics Recent Developments/Updates
Table 94. Peptilogics Competitive Strengths & Weaknesses
Table 95. Sealife PHARMA Basic Information, Manufacturing Base and Competitors
Table 96. Sealife PHARMA Major Business
Table 97. Sealife PHARMA Acinetobacter Infections Treatment Product and Services
Table 98. Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sealife PHARMA Recent Developments/Updates
Table 100. Sealife PHARMA Competitive Strengths & Weaknesses
Table 101. Shionogi Basic Information, Manufacturing Base and Competitors
Table 102. Shionogi Major Business
Table 103. Shionogi Acinetobacter Infections Treatment Product and Services
Table 104. Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shionogi Recent Developments/Updates
Table 106. Shionogi Competitive Strengths & Weaknesses
Table 107. Techulon Basic Information, Manufacturing Base and Competitors
Table 108. Techulon Major Business
Table 109. Techulon Acinetobacter Infections Treatment Product and Services
Table 110. Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Techulon Recent Developments/Updates
Table 112. Techulon Competitive Strengths & Weaknesses
Table 113. Tetraphase Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Tetraphase Pharmaceuticals Major Business
Table 115. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 116. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Tetraphase Pharmaceuticals Recent Developments/Updates
Table 118. Tetraphase Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Global Key Players of Acinetobacter Infections Treatment Upstream (Raw Materials)
Table 120. Global Acinetobacter Infections Treatment Typical Customers
LIST OF FIGURES
Figure 1. Acinetobacter Infections Treatment Picture
Figure 2. World Acinetobacter Infections Treatment Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Acinetobacter Infections Treatment Total Revenue (2021-2032) & (USD Million)
Figure 4. World Acinetobacter Infections Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Acinetobacter Infections Treatment Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 13. Acinetobacter Infections Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 16. World Acinetobacter Infections Treatment Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 18. China Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 23. India Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Acinetobacter Infections Treatment by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Acinetobacter Infections Treatment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Acinetobacter Infections Treatment Markets in 2025
Figure 27. United States VS China: Acinetobacter Infections Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Acinetobacter Infections Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Acinetobacter Infections Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Acinetobacter Infections Treatment Market Size Market Share by Type in 2025
Figure 31. Sulbactam
Figure 32. Carbapenems
Figure 33. Aminoglycosides
Figure 34. Polymyxins
Figure 35. Tetracyclines
Figure 36. Others
Figure 37. World Acinetobacter Infections Treatment Market Size Market Share by Type (2021-2032)
Figure 38. World Acinetobacter Infections Treatment Market Size by Pipeline, (USD Million), 2021 & 2025 & 2032
Figure 39. World Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2025
Figure 40. ETX2514
Figure 41. Nacubactam RG6080
Figure 42. Arenicin
Figure 43. VXD-001
Figure 44. Small Molecule Antibiotic
Figure 45. AR-401 mAB
Figure 46. LCB01-0371 (PO)
Figure 47. GN-4474
Figure 48. GN-4474
Figure 49. World Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2021-2032)
Figure 50. Acinetobacter Infections Treatment Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Acinetobacter Infections Treatment Picture
Figure 2. World Acinetobacter Infections Treatment Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Acinetobacter Infections Treatment Total Revenue (2021-2032) & (USD Million)
Figure 4. World Acinetobacter Infections Treatment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Acinetobacter Infections Treatment Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Acinetobacter Infections Treatment Revenue (2021-2032) & (USD Million)
Figure 13. Acinetobacter Infections Treatment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 16. World Acinetobacter Infections Treatment Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 18. China Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 23. India Acinetobacter Infections Treatment Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Acinetobacter Infections Treatment by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Acinetobacter Infections Treatment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Acinetobacter Infections Treatment Markets in 2025
Figure 27. United States VS China: Acinetobacter Infections Treatment Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Acinetobacter Infections Treatment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Acinetobacter Infections Treatment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Acinetobacter Infections Treatment Market Size Market Share by Type in 2025
Figure 31. Sulbactam
Figure 32. Carbapenems
Figure 33. Aminoglycosides
Figure 34. Polymyxins
Figure 35. Tetracyclines
Figure 36. Others
Figure 37. World Acinetobacter Infections Treatment Market Size Market Share by Type (2021-2032)
Figure 38. World Acinetobacter Infections Treatment Market Size by Pipeline, (USD Million), 2021 & 2025 & 2032
Figure 39. World Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2025
Figure 40. ETX2514
Figure 41. Nacubactam RG6080
Figure 42. Arenicin
Figure 43. VXD-001
Figure 44. Small Molecule Antibiotic
Figure 45. AR-401 mAB
Figure 46. LCB01-0371 (PO)
Figure 47. GN-4474
Figure 48. GN-4474
Figure 49. World Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2021-2032)
Figure 50. Acinetobacter Infections Treatment Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
